ArticleBMJ open2024

Designing a single-arm phase 2 clinical trial of mitapivat for adult patients with erythrocyte membranopathies (SATISFY): a framework for interventional trials in rare anaemias - pilot study protocol.

Andreas Glenthøj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.